Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-3634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-3634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3634 3)

Pdp (68071 3634 3)
Lansoprazole 15 mg delayed-release capsules label from NuCare Pharmaceuticals, Inc. The label indicates a package of 30 capsules with prescribing restriction (Rx Only). It includes manufacturer information, lot details, expiration date placeholders, serial numbers, and storage instructions to keep the product controlled at 68-77°F. The label also has barcodes and a warning to keep out of reach of children.*
FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

Lansoprazolefigure1 (Lansoprazolefigure1)
Line graph showing the mean severity of day heartburn by study day for evaluable patients, comparing placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. The x-axis represents days from the start of treatment, and the y-axis represents the mean severity of day heartburn on a scale from 0 (none) to 3 (severe).*
FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

Lansoprazolefigure2 (Lansoprazolefigure2)
A line graph titled 'Mean Severity of Night Heartburn By Study Day for Evaluable Patients,' showing severity levels over 60 days from treatment start. The graph compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with severity on the y-axis and days on the x-axis, illustrating changes in heartburn severity during the treatment period.*
FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

Lansoprazolestructure (Lansoprazolestructure)
Chemical structure diagram of lansoprazole, depicting its molecular framework including aromatic rings, sulfoxide group, and trifluoromethyl substituent as part of its formulation.*
FDA Label Image

Camber (Camber)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.